Xilis (Series A Extension)
Funding Details
- Awarder
- Inbox
- Date Award
- July 13, 2022
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $19,000,000
Company Info
- Founders
- Xiling Shen, PhD
- Company Description
- Xilis is a biotechnology company developing a precision oncology platform that guides treatment decisions for oncologists to improve cancer care outcomes for patients and enables drug discovery and development with pharmaceutical companies. Xilis' proprietary MicroOrganoSphere™ (MOS) technology consists of miniature patient tumors that capture the full microenvironment and heterogeneity and provides an automated and scalable solution.
- Market
- Precision Oncology
- Location
- Durham, North Carolina, USA
- Coinvestors
- Alexandria Venture Investments, Alix Ventures, Catalio Capital, Duke Angel Network, EQT Life Sciences, Felicis Ventures, FPV Ventures, GVMubadala Capital, Pear Ventures, Two Sigma Ventures